{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:14:24Z","timestamp":1793830464886,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0004"],"award-info":[{"award-number":["ANR-18-RHUS-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-IAHU-0004"],"award-info":[{"award-number":["ANR-23-IAHU-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EraPerMed","award":["iRECORDS JTC_2021"],"award-info":[{"award-number":["iRECORDS JTC_2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00134-026-08567-3","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:38:58Z","timestamp":1786603138000},"page":"1928-1942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Corticosteroids in ARDS: old controversies, new insights, and future directions"],"prefix":"10.1007","volume":"52","author":[{"given":"Tara","family":"Daoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6805-8944","authenticated-orcid":false,"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"8567_CR1","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1378\/chest.92.6.1032","volume":"92","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA (1987) Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032\u20131036","journal-title":"Chest"},{"key":"8567_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","volume":"317","author":"GR Bernard","year":"1987","unstructured":"Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565\u20131570. https:\/\/doi.org\/10.1056\/NEJM198712173172504","journal-title":"N Engl J Med"},{"key":"8567_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archsurg.1985.01390290018003","volume":"120","author":"JA Weigelt","year":"1985","unstructured":"Weigelt JA, Norcross JF, Borman KR, Snyder WH (1985) Early steroid therapy for respiratory failure. Arch Surg 120:536\u2013540","journal-title":"Arch Surg"},{"key":"8567_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM198709103171102","volume":"317","author":"Veterans Administration Systemic Sepsis Cooperative Study Group","year":"1987","unstructured":"Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659\u2013665","journal-title":"N Engl J Med"},{"key":"8567_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","volume":"138","author":"JM Luce","year":"1988","unstructured":"Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF (1988) Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 138:62\u201368","journal-title":"Am Rev Respir Dis"},{"key":"8567_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","volume":"23","author":"R Lefering","year":"1995","unstructured":"Lefering R, Neugebauer EAM (1995) Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 23:1294\u20131303","journal-title":"Crit Care Med"},{"key":"8567_CR7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","volume":"23","author":"L Cronin","year":"1995","unstructured":"Cronin L, Cook DJ, Carlet J et al (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430\u20131439","journal-title":"Crit Care Med"},{"key":"8567_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.280.2.159","volume":"280","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E et al (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159\u2013165","journal-title":"JAMA"},{"key":"8567_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archsurg.1985.01390290012002","volume":"120","author":"DG Ashbaugh","year":"1985","unstructured":"Ashbaugh DG, Maier RV (1985) Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch Surg 120:530\u2013535","journal-title":"Arch Surg"},{"key":"8567_CR10","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1183\/09031936.96.09122650","volume":"9","author":"GU Meduri","year":"1996","unstructured":"Meduri GU (1996) The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 9:2650\u20132670","journal-title":"Eur Respir J"},{"key":"8567_CR11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1378\/chest.105.5.1516","volume":"105","author":"GU Meduri","year":"1994","unstructured":"Meduri GU, Chinn AJ, Leeper KV et al (1994) Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 105:1516\u20131527","journal-title":"Chest"},{"issue":"5 Pt 1","key":"8567_CR12","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1164\/ajrccm.158.5.9801107","volume":"158","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A (1998) Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 158(5 Pt 1):1432\u20131441. https:\/\/doi.org\/10.1164\/ajrccm.158.5.9801107","journal-title":"Am J Respir Crit Care Med"},{"key":"8567_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671\u20131684","journal-title":"N Engl J Med"},{"key":"8567_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","volume":"34","author":"D Annane","year":"2006","unstructured":"Annane D, S\u00e9bille V, Bellissant E (2006) Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 34:22\u201330","journal-title":"Crit Care Med"},{"key":"8567_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ et al (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131:954\u2013963","journal-title":"Chest"},{"key":"8567_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA et al (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 8:267\u2013276","journal-title":"Lancet Respir Med"},{"key":"8567_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"RG Brower","year":"2000","unstructured":"Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301\u20131308","journal-title":"N Engl J Med"},{"key":"8567_CR18","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693\u2013704","DOI":"10.1056\/NEJMoa2021436"},{"key":"8567_CR19","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC et al (2020) Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 324:1307\u20131316","journal-title":"JAMA"},{"key":"8567_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A et al (2020) Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA 324:1317\u20131329","journal-title":"JAMA"},{"key":"8567_CR21","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","volume":"324","author":"PF Dequin","year":"2020","unstructured":"Dequin PF, Heming N, Meziani F, Plantefeve G, Voiriot G, Badie J et al (2020) Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. JAMA 324:1298\u20131306","journal-title":"JAMA"},{"key":"8567_CR22","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","volume":"72","author":"CMP Jeronimo","year":"2021","unstructured":"Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC et al (2021) Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019: the Metcovid randomized clinical trial. Clin Infect Dis 72:e373\u2013e381","journal-title":"Clin Infect Dis"},{"key":"8567_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00508-020-01805-8","volume":"133","author":"L Corral-Gudino","year":"2021","unstructured":"Corral-Gudino L, Bahamonde A, Arnaiz-Revillas F, Gomez-Barquero J, Abadia-Otero J, Garcia-Ibarbia C et al (2021) Methylprednisolone in adults hospitalized with COVID-19 pneumonia: an open-label randomized trial. Wien Klin Wochenschr 133:303\u2013311","journal-title":"Wien Klin Wochenschr"},{"key":"8567_CR24","doi-asserted-by":"publisher","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies REACT Working Group (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324:1330\u20131341. https:\/\/doi.org\/10.1001\/jama.2020.17023","DOI":"10.1001\/jama.2020.17023"},{"key":"8567_CR25","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000004899","volume":"49","author":"W Alhazzani","year":"2021","unstructured":"Alhazzani W, Evans L, Alshamsi F, M\u00f8ller MH, Ostermann M, Prescott HC et al (2021) Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 in the ICU: first update. Crit Care Med 49:e219\u2013e234. https:\/\/doi.org\/10.1097\/CCM.0000000000004899","journal-title":"Crit Care Med"},{"key":"8567_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379","volume":"370","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Agoritsas T, Macdonald H et al (2020) A living WHO guideline on drugs for covid-19. BMJ 370:m3379. https:\/\/doi.org\/10.1136\/bmj.m3379","journal-title":"BMJ"},{"key":"8567_CR27","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1136\/ard-2023-225371","volume":"83","author":"AK Eiers","year":"2024","unstructured":"Eiers AK, Vettorazzi S, Tuckermann JP (2024) Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases. Ann Rheum Dis 83:1603\u20131613. https:\/\/doi.org\/10.1136\/ard-2023-225371","journal-title":"Ann Rheum Dis"},{"key":"8567_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905\u20131917. https:\/\/doi.org\/10.1016\/S0140-6736(09)60326-3","journal-title":"Lancet"},{"key":"8567_CR29","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1073\/pnas.1606774113","volume":"113","author":"DM Presman","year":"2016","unstructured":"Presman DM, Ganguly S, Schiltz RL, Johnson TA, Karpova TS, Hager GL (2016) DNA binding triggers tetramerization of the glucocorticoid receptor in live cells. Proc Natl Acad Sci USA 113:8236\u20138241. https:\/\/doi.org\/10.1073\/pnas.1606774113","journal-title":"Proc Natl Acad Sci USA"},{"key":"8567_CR30","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-021-22234-9","volume":"12","author":"TA Johnson","year":"2021","unstructured":"Johnson TA, Paakinaho V, Kim S, Hager GL, Presman DM (2021) Genome-wide binding potential and regulatory activity of the glucocorticoid receptor\u2019s monomeric and dimeric forms. Nat Commun 12:1987. https:\/\/doi.org\/10.1038\/s41467-021-22234-9","journal-title":"Nat Commun"},{"key":"8567_CR31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1378\/chest.08-2408","volume":"136","author":"GU Meduri","year":"2009","unstructured":"Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE (2009) Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136:1631\u20131643","journal-title":"Chest"},{"key":"8567_CR32","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/CCM.0000000000002724","volume":"45","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W et al (2017) Critical illness-related corticosteroid insufficiency: a narrative review from a multispecialty task force of the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. Crit Care Med 45:2089\u20132098","journal-title":"Crit Care Med"},{"key":"8567_CR33","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","volume":"342","author":"LB Ware","year":"2000","unstructured":"Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334\u20131349","journal-title":"N Engl J Med"},{"key":"8567_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377:562\u2013572","journal-title":"N Engl J Med"},{"key":"8567_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-025-02127-9","volume":"10","author":"W Ma","year":"2025","unstructured":"Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P et al (2025) Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. Signal Transduct Target Ther 10:75","journal-title":"Signal Transduct Target Ther"},{"key":"8567_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0039-1683996","volume":"40","author":"LA Huppert","year":"2019","unstructured":"Huppert LA, Matthay MA, Ware LB (2019) Pathogenesis of acute respiratory distress syndrome. Semin Respir Crit Care Med 40:31\u201339. https:\/\/doi.org\/10.1055\/s-0039-1683996","journal-title":"Semin Respir Crit Care Med"},{"key":"8567_CR37","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R et al (2024) 2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med 52:e219\u2013e233","journal-title":"Crit Care Med"},{"key":"8567_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J et al (2024) An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 209:24\u201336. https:\/\/doi.org\/10.1164\/rccm.202311-2011ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8567_CR39","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.3390\/jcm14176088","volume":"14","author":"J Villar","year":"2025","unstructured":"Villar J, Szakmany T, Gajic O, Casali D, Cazorla-Rivero S, Niven AS (2025) ARDS subphenotypes as a guide to therapy and enrollment into therapeutic trials: not so fast. J Clin Med 14:6088. https:\/\/doi.org\/10.3390\/jcm14176088","journal-title":"J Clin Med"},{"key":"8567_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA et al (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611\u2013620","journal-title":"Lancet Respir Med"},{"key":"8567_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB (2022) Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet 400:1145\u20131156","journal-title":"Lancet"},{"key":"8567_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV et al (2021) Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med 204:1274\u20131285. https:\/\/doi.org\/10.1164\/rccm.202105-1302OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8567_CR43","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00134-025-08089-4","volume":"51","author":"J Pensier","year":"2025","unstructured":"Pensier J, Fosset M, Paschold BS, von Wedel D, Redaelli S, Braeuer BLP et al (2025) Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality. Intensive Care Med 51:1784\u20131796. https:\/\/doi.org\/10.1007\/s00134-025-08089-4","journal-title":"Intensive Care Med"},{"key":"8567_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK et al (2022) Redefining critical illness. Nat Med 28:1141\u20131148. https:\/\/doi.org\/10.1038\/s41591-022-01843-x","journal-title":"Nat Med"},{"key":"8567_CR45","doi-asserted-by":"publisher","first-page":"1277161","DOI":"10.3389\/fimmu.2023.1277161","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu H, Sheng S, Luo W, Xu X, Zhang Z (2023) Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup. Front Immunol 14:1277161","journal-title":"Front Immunol"},{"key":"8567_CR46","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388:1931\u20131941. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"8567_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot JP et al (2024) Hydrocortisone plus fludrocortisone for community-acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respir Med 12:366\u2013374. https:\/\/doi.org\/10.1016\/S2213-2600(23)00430-7","journal-title":"Lancet Respir Med"},{"key":"8567_CR48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","volume":"51","author":"T Pitre","year":"2025","unstructured":"Pitre T, Pauley E, Chaudhuri D, Saha R, Rudd KE, Villar J et al (2025) Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis. Intensive Care Med 51:917\u2013929. https:\/\/doi.org\/10.1007\/s00134-025-07912-2","journal-title":"Intensive Care Med"},{"key":"8567_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.7326\/ANNALS-25-03055","volume":"179","author":"A Soumare","year":"2026","unstructured":"Soumare A, Kapfer T, Botrel T, Adda L, Renaux M, Blot PL et al (2026) Systemic corticosteroids, mortality, and infections in pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. Ann Intern Med 179:67\u201380. https:\/\/doi.org\/10.7326\/ANNALS-25-03055","journal-title":"Ann Intern Med"},{"key":"8567_CR50","doi-asserted-by":"publisher","first-page":"CD010406","DOI":"10.1002\/14651858.CD010406.pub3","volume":"2","author":"L Lansbury","year":"2019","unstructured":"Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2019) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2:CD010406. https:\/\/doi.org\/10.1002\/14651858.CD010406.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"8567_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-103119","volume":"15","author":"JM Ramos-Rinc\u00f3n","year":"2025","unstructured":"Ramos-Rinc\u00f3n JM, Cebollada J, Giner L et al (2025) Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection: the FLUDEX study protocol for a randomised controlled trial in Spain. BMJ Open 15:e103119. https:\/\/doi.org\/10.1136\/bmjopen-2025-103119","journal-title":"BMJ Open"},{"issue":"Suppl 3","key":"8567_CR52","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1093\/infdis\/jiaf276","volume":"232","author":"AAC Waite","year":"2025","unstructured":"Waite AAC, Peto L, Gordon AC, Horby P (2025) Platform trials to assess therapeutics in patients hospitalized with influenza. J Infect Dis 232(Suppl 3):S254\u2013S261. https:\/\/doi.org\/10.1093\/infdis\/jiaf276","journal-title":"J Infect Dis"},{"key":"8567_CR53","doi-asserted-by":"publisher","first-page":"CD006150","DOI":"10.1002\/14651858.CD006150.pub2","volume":"2015","author":"H Ewald","year":"2015","unstructured":"Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 2015:CD006150. https:\/\/doi.org\/10.1002\/14651858.CD006150.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"8567_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arbres.2016.06.016","volume":"53","author":"Y Fujikura","year":"2017","unstructured":"Fujikura Y, Manabe T, Kawana A, Kohno S (2017) Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV-infected patients: a systematic review and meta-analysis of observational studies. Arch Bronconeumol 53:55\u201361. https:\/\/doi.org\/10.1016\/j.arbres.2016.06.016","journal-title":"Arch Bronconeumol"},{"key":"8567_CR55","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","volume":"13","author":"V Lemiale","year":"2025","unstructured":"Lemiale V, Resche-Rigon M, Zerbib Y et al (2025) Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia: a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 13:800\u2013808","journal-title":"Lancet Respir Med"},{"key":"8567_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223504","author":"F Reizine","year":"2025","unstructured":"Reizine F, Stiegler V, Lecuyer R, Tessoulin B, Rieul G, Camou F et al (2025) Prognostic impact and safety of early adjunctive corticosteroid therapy in HIV-negative severe pneumocystis pneumonia: a propensity-matched multicentre study. Thorax. https:\/\/doi.org\/10.1136\/thorax-2025-223504","journal-title":"Thorax"},{"key":"8567_CR57","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.burns.2017.11.013","volume":"44","author":"CJ Deutsch","year":"2018","unstructured":"Deutsch CJ, Tan A, Smailes S, Dziewulski P (2018) The diagnosis and management of inhalation injury: an evidence-based approach. Burns 44:1040\u20131051. https:\/\/doi.org\/10.1016\/j.burns.2017.11.013","journal-title":"Burns"},{"key":"8567_CR58","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa022450","volume":"348","author":"MS Herridge","year":"2003","unstructured":"Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F et al (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683\u2013693. https:\/\/doi.org\/10.1056\/NEJMoa022450","journal-title":"N Engl J Med"},{"key":"8567_CR59","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMra2104669","volume":"388","author":"MS Herridge","year":"2023","unstructured":"Herridge MS, Azoulay \u00c9 (2023) Outcomes after critical illness. N Engl J Med 388:913\u2013924. https:\/\/doi.org\/10.1056\/NEJMra2104669","journal-title":"N Engl J Med"},{"key":"8567_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001071","volume":"6","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Israelian L, Putowski Z, Prakash J, Pitre T, Nei AM et al (2024) Adverse effects related to corticosteroid use in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia: a systematic review and meta-analysis. Crit Care Explor 6:e1071. https:\/\/doi.org\/10.1097\/CCE.0000000000001071","journal-title":"Crit Care Explor"},{"key":"8567_CR61","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1007\/s00134-025-08046-1","volume":"51","author":"N Heming","year":"2025","unstructured":"Heming N, Berry L, Lorenzi E, Berry S, Angus DC (2025) Correspondence about the article \u201cEffect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: the REMAP-CAP corticosteroid domain randomized clinical trial\u201d: author\u2019s reply. Intensive Care Med 51:1742\u20131743. https:\/\/doi.org\/10.1007\/s00134-025-08046-1","journal-title":"Intensive Care Med"},{"key":"8567_CR62","unstructured":"Glucocorticoids in adults with acute respiratory distress syndrome: GuARDS trial. https:\/\/guards-trial.ed.ac.uk\/. Accessed 17 May 2026."},{"key":"8567_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066496","volume":"13","author":"J Fleuriet","year":"2023","unstructured":"Fleuriet J, Heming N, Meziani F, Reignier J, Declerq PL, Mercier E et al (2023) Rapid recognition of corticosteroid resistant or sensitive sepsis: study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial. BMJ Open 13:e066496. https:\/\/doi.org\/10.1136\/bmjopen-2022-066496","journal-title":"BMJ Open"},{"key":"8567_CR64","doi-asserted-by":"publisher","first-page":"16843","DOI":"10.3390\/ijms242316843","volume":"24","author":"GJ Albers","year":"2023","unstructured":"Albers GJ, Amouret A, Ciupka K, Montes-Cobos E, Feldmann C, Reichardt HM (2023) Glucocorticoid nanoparticles show full therapeutic efficacy in a mouse model of acute lung injury and concomitantly reduce adverse effects. Int J Mol Sci 24:16843. https:\/\/doi.org\/10.3390\/ijms242316843","journal-title":"Int J Mol Sci"},{"key":"8567_CR65","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/pharmaceutics16070878","volume":"16","author":"HH Chen","year":"2024","unstructured":"Chen HH, Sang CH, Chou CW, Lin YT, Chang YS, Chiu HC (2024) Solid lipid nanoparticles loaded with dexamethasone palmitate for pulmonary inflammation treatment by nebulization approach. Pharmaceutics 16:878. https:\/\/doi.org\/10.3390\/pharmaceutics16070878","journal-title":"Pharmaceutics"},{"key":"8567_CR66","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/pharmaceutics13091347","volume":"13","author":"S Kotta","year":"2021","unstructured":"Kotta S, Aldawsari HM, Badr-Eldin SM, Binmahfouz LS, Bakhaidar RB, Sreeharsha N et al (2021) Lung-targeted lipopolymeric microspheres of dexamethasone for the treatment of ARDS. Pharmaceutics 13:1347. https:\/\/doi.org\/10.3390\/pharmaceutics13091347","journal-title":"Pharmaceutics"},{"key":"8567_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2021.07.010","volume":"337","author":"A Garc\u00eda-Fern\u00e1ndez","year":"2021","unstructured":"Garc\u00eda-Fern\u00e1ndez A, Sancho M, Bisbal V, Amor\u00f3s P, Marcos MD, Orz\u00e1ez M et al (2021) Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles: a new therapeutic approach for acute lung injury treatment. J Control Release 337:14\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2021.07.010","journal-title":"J Control Release"},{"key":"8567_CR68","doi-asserted-by":"publisher","first-page":"175346662412449","DOI":"10.1177\/17534666241244974","volume":"18","author":"X Chen","year":"2024","unstructured":"Chen X, Tang Z (2024) Novel application of nanomedicine for the treatment of acute lung injury: a literature review. Ther Adv Respir Dis 18:17534666241244974. https:\/\/doi.org\/10.1177\/17534666241244974","journal-title":"Ther Adv Respir Dis"},{"key":"8567_CR69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2025.06.005","volume":"46","author":"F Buttgereit","year":"2025","unstructured":"Buttgereit F, Elling C, Jakob F (2025) Design and development of glucocorticoid receptor modulators. Trends Pharmacol Sci 46:771\u2013791. https:\/\/doi.org\/10.1016\/j.tips.2025.06.005","journal-title":"Trends Pharmacol Sci"},{"key":"8567_CR70","doi-asserted-by":"publisher","first-page":"1542351","DOI":"10.3389\/fphar.2025.1542351","volume":"16","author":"F Jakob","year":"2025","unstructured":"Jakob F, Hennen S, Gautrois M, Khalil F, Lockhart A (2025) Novel selective glucocorticoid receptor modulator GRM-01 demonstrates dissociation of anti-inflammatory effects from adverse effects on glucose and bone metabolism. Front Pharmacol 16:1542351. https:\/\/doi.org\/10.3389\/fphar.2025.1542351","journal-title":"Front Pharmacol"},{"key":"8567_CR71","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/s41401-021-00855-6","volume":"43","author":"JP Pang","year":"2022","unstructured":"Pang JP, Hu XP, Wang YX et al (2022) Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays. Acta Pharmacol Sin 43:2429\u20132438. https:\/\/doi.org\/10.1038\/s41401-021-00855-6","journal-title":"Acta Pharmacol Sin"},{"key":"8567_CR72","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1111\/cts.13624","volume":"16","author":"JM van Laar","year":"2023","unstructured":"van Laar JM, Lei A, Safy-Khan M, Almquist J, Belfield G, Edman K et al (2023) AZD9567 versus prednisolone in patients with active rheumatoid arthritis: a phase IIa, randomized, double-blind, efficacy, and safety study. Clin Transl Sci 16:2494\u20132506. https:\/\/doi.org\/10.1111\/cts.13624","journal-title":"Clin Transl Sci"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08567-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08567-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08567-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:40:52Z","timestamp":1789047652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08567-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8567"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08567-3","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JV has investigated the effects of corticosteroids in ARDS and other critical illnesses. DA has investigated the effects of corticosteroids in ARDS and other critical illnesses. DA is a Section Editor for Intensive Care Medicine. He has not taken part in the review or selection process of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}